Free Trial

Evolus (EOLS) Financials

Evolus logo
$11.65 +0.10 (+0.87%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$11.78 +0.13 (+1.07%)
As of 04/25/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Evolus

Annual Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
-74 -62 -50
Consolidated Net Income / (Loss)
-74 -62 -50
Net Income / (Loss) Continuing Operations
-74 -62 -50
Total Pre-Tax Income
-74 -62 -50
Total Operating Income
-65 -49 -34
Total Gross Profit
90 138 182
Total Revenue
149 202 266
Operating Revenue
149 202 266
Total Cost of Revenue
59 65 84
Operating Cost of Revenue
59 65 84
Total Operating Expenses
155 187 217
Selling, General & Admin Expense
142 165 198
Research & Development Expense
6.74 15 9.17
Depreciation Expense
0.77 2.18 2.34
Other Operating Expenses / (Income)
- 4.26 7.18
Total Other Income / (Expense), net
-8.99 -12 -15
Interest Expense
9.10 14 19
Interest & Investment Income
0.12 0.86 3.26
Other Income / (Expense), net
-0.01 0.70 0.13
Income Tax Expense
0.10 0.18 0.66
Basic Earnings per Share
($1.33) ($1.08) ($0.81)
Weighted Average Basic Shares Outstanding
56.07M 56.92M 62.02M
Diluted Earnings per Share
($1.33) ($1.08) ($0.81)
Weighted Average Diluted Shares Outstanding
56.07M 56.92M 62.02M
Weighted Average Basic & Diluted Shares Outstanding
56.41M 57.94M 63.59M

Quarterly Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.79
Consolidated Net Income / (Loss)
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.79
Net Income / (Loss) Continuing Operations
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.79
Total Pre-Tax Income
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.35
Total Operating Income
-18 -11 -12 -15 -13 -8.64 -8.92 -7.70 -15 -2.31
Total Gross Profit
20 27 30 35 35 39 41 48 43 50
Total Revenue
34 44 42 49 50 61 59 67 61 79
Operating Revenue
34 44 42 49 50 61 59 67 61 79
Total Cost of Revenue
13 16 12 15 15 22 18 19 18 29
Operating Cost of Revenue
13 16 12 15 15 22 18 19 18 29
Total Operating Expenses
38 38 42 50 48 47 50 56 58 53
Selling, General & Admin Expense
35 37 37 41 43 43 45 50 53 50
Research & Development Expense
1.38 1.35 1.38 5.65 1.59 6.81 2.08 2.35 2.31 2.43
Depreciation Expense
0.92 -1.93 1.20 1.25 1.31 -1.58 1.41 1.43 1.09 -1.58
Total Other Income / (Expense), net
-2.37 -2.47 -2.73 -3.00 -3.46 -3.09 -4.14 -3.61 -3.56 -4.04
Interest Expense
2.34 2.63 2.79 3.18 3.79 4.08 4.70 4.70 4.76 4.57
Interest & Investment Income
0.04 0.08 0.10 0.16 0.31 0.29 0.52 1.03 0.93 0.79
Other Income / (Expense), net
-0.06 0.08 -0.04 0.02 0.02 0.69 0.05 0.06 0.27 -0.25
Income Tax Expense
0.01 0.06 0.02 0.02 0.02 0.11 0.05 0.04 0.13 0.44
Basic Earnings per Share
($0.36) ($0.24) ($0.26) ($0.32) ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11)
Weighted Average Basic Shares Outstanding
56.18M 56.07M 56.48M 56.92M 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M
Diluted Earnings per Share
($0.36) ($0.24) ($0.26) ($0.32) ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11)
Weighted Average Diluted Shares Outstanding
56.18M 56.07M 56.48M 56.92M 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M
Weighted Average Basic & Diluted Shares Outstanding
56.25M 56.41M 56.92M 56.97M 57.15M 57.94M 62.61M 63.09M 63.32M 63.59M

Annual Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents
-92 8.92 24
Net Cash From Operating Activities
-85 -34 -18
Net Cash From Continuing Operating Activities
-85 -34 -18
Net Income / (Loss) Continuing Operations
-74 -62 -50
Consolidated Net Income / (Loss)
-74 -62 -50
Depreciation Expense
3.72 5.13 5.30
Amortization Expense
1.86 1.85 1.87
Non-Cash Adjustments To Reconcile Net Income
-2.57 17 25
Changes in Operating Assets and Liabilities, net
-14 3.37 0.55
Net Cash From Investing Activities
-2.94 -1.63 -4.82
Net Cash From Continuing Investing Activities
-2.94 -1.63 -4.82
Purchase of Property, Plant & Equipment
-2.94 -1.63 -4.82
Net Cash From Financing Activities
-4.15 45 47
Net Cash From Continuing Financing Activities
-4.15 45 47
Repayment of Debt
-0.50 -0.05 0.00
Repurchase of Common Equity
0.00 0.00 -0.25
Issuance of Debt
0.00 50 0.00
Issuance of Common Equity
0.00 0.00 51
Other Financing Activities, net
-3.65 -5.31 -3.55
Effect of Exchange Rate Changes
-0.34 -0.09 -0.48
Cash Interest Paid
8.00 13 18
Cash Income Taxes Paid
0.08 0.12 0.24

Quarterly Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-19 -12 -22 10 -3.02 24 34 -3.29 -8.64 1.92
Net Cash From Operating Activities
-17 -8.77 -21 -13 -0.92 0.81 -11 -6.47 -5.72 4.81
Net Cash From Continuing Operating Activities
-17 -8.77 -21 -13 -0.92 0.81 -11 -6.47 -5.72 4.81
Net Income / (Loss) Continuing Operations
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.79
Consolidated Net Income / (Loss)
-20 -13 -15 -18 -17 -12 -13 -11 -19 -6.79
Depreciation Expense
0.92 1.03 1.20 1.25 1.31 1.37 1.41 1.43 1.09 1.37
Amortization Expense
0.47 0.48 0.51 0.49 0.43 0.42 0.43 0.44 0.47 0.54
Non-Cash Adjustments To Reconcile Net Income
3.11 2.65 -1.43 4.24 5.61 8.91 5.27 6.37 6.11 6.96
Changes in Operating Assets and Liabilities, net
-1.27 0.23 -6.07 -1.15 8.65 1.94 -4.61 -3.35 5.78 2.73
Net Cash From Investing Activities
-0.90 -1.39 -0.51 -0.22 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36
Net Cash From Continuing Investing Activities
-0.90 -1.39 -0.51 -0.22 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36
Purchase of Property, Plant & Equipment
-0.90 -1.39 -0.51 -0.22 -0.54 -0.36 -0.80 -1.25 -1.41 -1.36
Net Cash From Financing Activities
-0.76 -1.52 -1.28 24 -1.42 24 46 4.48 -1.42 -1.31
Net Cash From Continuing Financing Activities
-0.76 -1.52 -1.28 24 -1.42 24 46 4.48 -1.42 -1.31
Issuance of Common Equity
0.36 -0.54 0.03 0.11 0.06 -0.20 47 6.51 0.59 -3.38
Other Financing Activities, net
-1.11 -0.48 -1.31 -1.25 -1.48 -1.28 -1.83 -1.78 -2.01 2.06
Effect of Exchange Rate Changes
-0.20 0.03 -0.08 -0.05 -0.14 0.18 -0.13 -0.04 -0.09 -0.22
Cash Interest Paid
2.07 2.35 0.00 5.39 3.52 3.80 4.42 4.41 4.47 4.23
Cash Income Taxes Paid
0.02 0.01 0.03 0.03 0.04 0.02 0.03 0.14 0.03 0.04

Annual Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Total Assets
178 189 233
Total Current Assets
101 112 151
Cash & Equivalents
54 63 87
Accounts Receivable
22 31 48
Inventories, net
19 11 12
Prepaid Expenses
3.90 5.70 3.35
Other Current Assets
1.68 2.36 1.20
Plant, Property, & Equipment, net
2.62 2.09 3.22
Total Noncurrent Assets
75 74 78
Goodwill
21 21 21
Intangible Assets
49 47 49
Other Noncurrent Operating Assets
4.76 6.17 8.04
Total Liabilities & Shareholders' Equity
178 189 233
Total Liabilities
159 210 227
Total Current Liabilities
47 48 63
Accounts Payable
8.94 4.27 9.24
Accrued Expenses
25 34 41
Other Current Liabilities
13 10 13
Total Noncurrent Liabilities
113 161 164
Long-Term Debt
72 120 122
Noncurrent Deferred & Payable Income Tax Liabilities
0.02 0.03 0.01
Other Noncurrent Operating Liabilities
41 41 43
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
18 -21 5.52
Total Preferred & Common Equity
18 -21 5.52
Preferred Stock
0.00 0.00 0.00
Total Common Equity
18 -21 5.52
Common Stock
516 539 616
Retained Earnings
-497 -559 -609
Accumulated Other Comprehensive Income / (Loss)
-0.34 -0.43 -0.91

Quarterly Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
193 160 169 168 226 234 230
Total Current Assets
116 84 96 92 150 158 150
Cash & Equivalents
66 31 42 39 97 94 85
Accounts Receivable
21 23 29 30 34 43 45
Inventories, net
22 23 20 18 12 13 15
Prepaid Expenses
3.66 4.16 4.30 3.66 5.68 5.51 3.40
Other Current Assets
4.23 1.59 1.60 1.57 1.84 2.43 2.39
Plant, Property, & Equipment, net
1.88 2.60 2.35 2.13 2.09 2.28 2.31
Total Noncurrent Assets
75 74 70 74 74 73 77
Goodwill
21 21 21 21 21 21 21
Intangible Assets
49 48 47 47 47 46 47
Other Noncurrent Operating Assets
4.58 4.42 1.75 6.13 6.02 5.87 9.14
Total Liabilities & Shareholders' Equity
193 160 169 168 226 234 230
Total Liabilities
163 153 176 187 208 214 224
Total Current Liabilities
51 41 41 49 47 54 61
Accounts Payable
8.56 10 7.84 12 11 10 14
Accrued Expenses
30 22 24 27 25 33 35
Other Current Liabilities
13 8.38 9.33 10 11 11 12
Total Noncurrent Liabilities
112 113 135 139 161 160 163
Long-Term Debt
72 72 95 95 121 121 121
Noncurrent Deferred & Payable Income Tax Liabilities
0.03 0.02 0.02 0.02 0.03 0.03 0.03
Other Noncurrent Operating Liabilities
40 41 40 44 40 39 42
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
29 6.95 -6.96 -19 18 19 5.89
Total Preferred & Common Equity
29 6.95 -6.96 -19 18 19 5.89
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
29 6.95 -6.96 -19 18 19 5.89
Common Stock
514 519 524 528 591 603 609
Retained Earnings
-484 -512 -530 -547 -572 -583 -603
Accumulated Other Comprehensive Income / (Loss)
-0.37 -0.42 -0.47 -0.61 -0.56 -0.60 -0.69

Annual Metrics and Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric 2022 2023 2024
Growth Metrics
- - -
Revenue Growth
49.10% 35.98% 31.76%
EBITDA Growth
-62.04% 30.46% 34.74%
EBIT Growth
-47.14% 25.72% 29.37%
NOPAT Growth
-47.12% 24.64% 30.11%
Net Income Growth
-58.97% 17.10% 18.26%
EPS Growth
-41.49% 18.80% 25.00%
Operating Cash Flow Growth
-154.32% 59.95% 47.07%
Free Cash Flow Firm Growth
10.82% 53.76% 21.55%
Invested Capital Growth
432.83% 1.03% 8.81%
Revenue Q/Q Growth
6.44% 9.39% 7.23%
EBITDA Q/Q Growth
11.22% 6.51% 16.85%
EBIT Q/Q Growth
10.27% 5.11% 13.55%
NOPAT Q/Q Growth
10.16% 3.91% 15.52%
Net Income Q/Q Growth
6.31% 2.12% 9.09%
EPS Q/Q Growth
13.07% 3.57% 10.00%
Operating Cash Flow Q/Q Growth
0.32% 21.99% 18.16%
Free Cash Flow Firm Q/Q Growth
1.78% 7.21% 18.50%
Invested Capital Q/Q Growth
3.10% -0.56% -4.72%
Profitability Metrics
- - -
Gross Margin
60.41% 68.08% 68.46%
EBITDA Margin
-40.21% -20.56% -10.18%
Operating Margin
-43.96% -24.36% -12.92%
EBIT Margin
-43.97% -24.02% -12.88%
Profit (Net Income) Margin
-50.07% -30.52% -18.94%
Tax Burden Percent
100.13% 100.29% 101.33%
Interest Burden Percent
113.74% 126.73% 145.13%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-211.24% -94.05% -62.64%
ROIC Less NNEP Spread (ROIC-NNEP)
-110.74% -166.18% -119.84%
Return on Net Nonoperating Assets (RNNOA)
62.97% 5,727.38% 727.50%
Return on Equity (ROE)
-148.27% 5,633.33% 664.86%
Cash Return on Invested Capital (CROIC)
-348.03% -95.07% -71.08%
Operating Return on Assets (OROA)
-30.01% -26.45% -16.27%
Return on Assets (ROA)
-34.18% -33.62% -23.92%
Return on Common Equity (ROCE)
-148.27% 5,633.33% 664.86%
Return on Equity Simple (ROE_SIMPLE)
-402.25% 298.15% -913.08%
Net Operating Profit after Tax (NOPAT)
-46 -34 -24
NOPAT Margin
-30.77% -17.05% -9.05%
Net Nonoperating Expense Percent (NNEP)
-100.50% 72.13% 57.20%
Return On Investment Capital (ROIC_SIMPLE)
-50.60% -34.58% -18.96%
Cost of Revenue to Revenue
39.59% 31.92% 31.54%
SG&A Expenses to Revenue
95.44% 81.62% 74.37%
R&D to Revenue
4.54% 7.63% 3.44%
Operating Expenses to Revenue
104.37% 92.44% 81.39%
Earnings before Interest and Taxes (EBIT)
-65 -49 -34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-60 -42 -27
Valuation Ratios
- - -
Price to Book Value (P/BV)
22.83 0.00 126.60
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00
Price to Revenue (P/Rev)
2.84 2.98 2.63
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
12.08 17.90 18.31
Enterprise Value to Revenue (EV/Rev)
2.96 3.26 2.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
3.89 -5.82 22.00
Long-Term Debt to Equity
3.89 -5.82 22.00
Financial Leverage
-0.57 -34.46 -6.07
Leverage Ratio
4.34 -167.57 -27.80
Compound Leverage Factor
4.93 -212.36 -40.34
Debt to Total Capital
79.53% 120.76% 95.65%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
79.53% 120.76% 95.65%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
20.47% -20.76% 4.35%
Debt to EBITDA
-1.20 -2.90 -4.48
Net Debt to EBITDA
-0.30 -1.38 -1.27
Long-Term Debt to EBITDA
-1.20 -2.90 -4.48
Debt to NOPAT
-1.57 -3.49 -5.04
Net Debt to NOPAT
-0.39 -1.67 -1.43
Long-Term Debt to NOPAT
-1.57 -3.49 -5.04
Altman Z-Score
-2.33 -1.79 -0.71
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
2.17 2.33 2.40
Quick Ratio
1.64 1.93 2.14
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-75 -35 -27
Operating Cash Flow to CapEx
-2,889.15% -2,090.23% -373.19%
Free Cash Flow to Firm to Interest Expense
-8.28 -2.52 -1.46
Operating Cash Flow to Interest Expense
-9.33 -2.46 -0.96
Operating Cash Flow Less CapEx to Interest Expense
-9.66 -2.58 -1.22
Efficiency Ratios
- - -
Asset Turnover
0.68 1.10 1.26
Accounts Receivable Turnover
8.01 7.63 6.81
Inventory Turnover
5.71 4.32 7.25
Fixed Asset Turnover
74.55 85.94 100.31
Accounts Payable Turnover
7.83 9.77 12.43
Days Sales Outstanding (DSO)
45.56 47.84 53.60
Days Inventory Outstanding (DIO)
63.93 84.44 50.33
Days Payable Outstanding (DPO)
46.60 37.36 29.36
Cash Conversion Cycle (CCC)
62.90 94.93 74.58
Capital & Investment Metrics
- - -
Invested Capital
36 37 40
Invested Capital Turnover
6.86 5.51 6.92
Increase / (Decrease) in Invested Capital
30 0.38 3.24
Enterprise Value (EV)
440 659 734
Market Capitalization
422 602 699
Book Value per Share
$0.33 ($0.36) $0.09
Tangible Book Value per Share
($0.91) ($1.56) ($1.02)
Total Capital
90 100 127
Total Debt
72 120 122
Total Long-Term Debt
72 120 122
Net Debt
18 58 35
Capital Expenditures (CapEx)
2.94 1.63 4.82
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.37 1.29 1.43
Debt-free Net Working Capital (DFNWC)
54 64 88
Net Working Capital (NWC)
54 64 88
Net Nonoperating Expense (NNE)
29 27 26
Net Nonoperating Obligations (NNO)
18 58 35
Total Depreciation and Amortization (D&A)
5.58 6.98 7.17
Debt-free, Cash-free Net Working Capital to Revenue
0.25% 0.64% 0.54%
Debt-free Net Working Capital to Revenue
36.53% 31.73% 33.19%
Net Working Capital to Revenue
36.53% 31.73% 33.19%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($1.33) ($1.08) ($0.81)
Adjusted Weighted Average Basic Shares Outstanding
56.07M 56.92M 62.02M
Adjusted Diluted Earnings per Share
($1.33) ($1.08) ($0.81)
Adjusted Weighted Average Diluted Shares Outstanding
56.07M 56.92M 62.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.41M 57.94M 63.59M
Normalized Net Operating Profit after Tax (NOPAT)
-42 -34 -24
Normalized NOPAT Margin
-28.06% -17.05% -9.05%
Pre Tax Income Margin
-50.01% -30.44% -18.69%
Debt Service Ratios
- - -
EBIT to Interest Expense
-7.18 -3.51 -1.83
NOPAT to Interest Expense
-5.03 -2.49 -1.29
EBIT Less CapEx to Interest Expense
-7.51 -3.63 -2.09
NOPAT Less CapEx to Interest Expense
-5.35 -2.61 -1.54
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -0.49%

Quarterly Metrics and Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
27.07% 25.94% 23.04% 32.78% 47.55% 39.76% 42.21% 35.59% 22.12% 29.42%
EBITDA Growth
6.43% 45.51% 26.38% 33.40% 29.54% 31.98% 32.08% 56.75% -16.81% 89.32%
EBIT Growth
6.02% 41.46% 21.85% 29.35% 25.28% 24.75% 26.50% 49.40% -13.27% 67.67%
NOPAT Growth
6.35% 41.00% 22.06% 29.18% 24.90% 18.82% 25.90% 49.05% -15.13% 73.20%
Net Income Growth
-4.34% 27.58% 15.48% 22.71% 16.54% 10.13% 11.37% 37.43% -13.28% 42.60%
EPS Growth
-2.86% 45.45% 16.13% 23.81% 16.67% 16.67% 15.38% 43.75% 0.00% 45.00%
Operating Cash Flow Growth
46.92% 2.99% 46.11% 36.28% 94.58% 109.27% 48.44% 51.39% -519.26% 491.39%
Free Cash Flow Firm Growth
-209.54% 43.87% -7.63% 58.37% 71.07% 82.68% 96.52% 74.62% -42.96% 24.25%
Invested Capital Growth
269.95% 432.83% 48.73% 36.08% 4.75% 1.03% -11.38% 0.87% 13.56% 8.81%
Revenue Q/Q Growth
-8.78% 28.75% -4.41% 18.28% 1.36% 21.95% -2.73% 12.77% -8.70% 29.24%
EBITDA Q/Q Growth
17.39% 45.43% -14.66% -28.83% 12.59% 47.32% -14.50% 17.96% -136.05% 95.18%
EBIT Q/Q Growth
15.97% 41.24% -14.45% -25.01% 11.13% 40.82% -11.79% 13.93% -98.95% 83.11%
NOPAT Q/Q Growth
16.17% 40.57% -13.19% -25.56% 11.10% 35.75% -3.32% 13.67% -100.90% 85.04%
Net Income Q/Q Growth
13.61% 35.08% -12.36% -22.64% 6.71% 30.09% -10.80% 13.42% -68.90% 64.57%
EPS Q/Q Growth
14.29% 33.33% -8.33% -23.08% 6.25% 33.33% -10.00% 18.18% -66.67% 63.33%
Operating Cash Flow Q/Q Growth
18.37% 48.54% -134.64% 35.35% 93.06% 187.99% -1,405.66% 39.05% 11.56% 184.03%
Free Cash Flow Firm Q/Q Growth
30.08% 3.31% 35.23% 4.92% 51.41% 42.10% 87.00% -594.08% -173.74% 69.32%
Invested Capital Q/Q Growth
4.24% 3.10% 30.38% -2.88% -19.76% -0.56% 14.36% 10.54% -9.66% -4.72%
Profitability Metrics
- - - - - - - - - -
Gross Margin
60.21% 62.60% 70.89% 70.19% 69.15% 63.57% 69.55% 71.49% 70.17% 63.77%
EBITDA Margin
-48.88% -20.72% -24.85% -27.07% -23.34% -10.08% -11.87% -8.64% -22.33% -0.83%
Operating Margin
-52.80% -24.37% -28.86% -30.64% -26.87% -14.16% -15.04% -11.51% -25.33% -2.93%
EBIT Margin
-52.98% -24.18% -28.95% -30.60% -26.83% -13.02% -14.96% -11.42% -24.88% -3.25%
Profit (Net Income) Margin
-59.81% -30.16% -35.45% -36.76% -33.83% -19.40% -22.09% -16.96% -31.38% -8.60%
Tax Burden Percent
100.06% 100.43% 100.16% 100.13% 100.14% 100.90% 100.36% 100.38% 100.70% 106.93%
Interest Burden Percent
112.83% 124.20% 122.27% 119.99% 125.93% 147.65% 147.14% 148.00% 125.24% 247.41%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-229.76% -117.11% -79.51% -90.31% -95.98% -54.65% -51.59% -41.24% -111.32% -14.21%
ROIC Less NNEP Spread (ROIC-NNEP)
-210.79% -97.08% -319.94% -127.92% -120.01% -69.98% -72.95% -56.06% -129.34% -25.44%
Return on Net Nonoperating Assets (RNNOA)
136.02% 55.20% -22.82% -128.84% -761.93% 2,411.86% -184.62% -364.83% 888.44% 154.44%
Return on Equity (ROE)
-93.74% -61.91% -102.33% -219.15% -857.92% 2,357.21% -236.21% -406.07% 777.12% 140.23%
Cash Return on Invested Capital (CROIC)
-341.54% -348.03% -148.24% -127.93% -103.72% -95.07% -59.94% -59.29% -84.79% -71.08%
Operating Return on Assets (OROA)
-36.27% -16.50% -23.78% -27.16% -27.48% -14.34% -17.01% -13.45% -31.08% -4.11%
Return on Assets (ROA)
-40.94% -20.59% -29.12% -32.63% -34.66% -21.36% -25.12% -19.99% -39.20% -10.87%
Return on Common Equity (ROCE)
-93.74% -61.91% -102.33% -219.15% -857.92% 2,357.21% -236.21% -406.07% 777.12% 140.23%
Return on Equity Simple (ROE_SIMPLE)
-271.82% 0.00% -1,031.83% 953.20% 325.37% 0.00% -325.34% -275.52% -941.60% 0.00%
Net Operating Profit after Tax (NOPAT)
-13 -7.45 -8.43 -11 -9.41 -6.04 -6.25 -5.39 -11 -1.62
NOPAT Margin
-36.96% -17.06% -20.20% -21.45% -18.81% -9.91% -10.53% -8.06% -17.73% -2.05%
Net Nonoperating Expense Percent (NNEP)
-18.97% -20.04% 240.43% 37.61% 24.03% 15.33% 21.36% 14.83% 18.01% 11.23%
Return On Investment Capital (ROIC_SIMPLE)
- -8.24% - - - -6.06% - - - -1.28%
Cost of Revenue to Revenue
39.79% 37.40% 29.11% 29.81% 30.85% 36.44% 30.45% 28.51% 29.83% 36.23%
SG&A Expenses to Revenue
102.64% 84.15% 89.60% 83.44% 86.62% 70.59% 76.05% 74.96% 85.96% 63.64%
R&D to Revenue
4.06% 3.09% 3.31% 11.45% 3.17% 11.16% 3.50% 3.51% 3.79% 3.08%
Operating Expenses to Revenue
113.00% 86.97% 99.75% 100.82% 96.02% 77.72% 84.59% 83.00% 95.50% 66.70%
Earnings before Interest and Taxes (EBIT)
-18 -11 -12 -15 -13 -7.94 -8.88 -7.64 -15 -2.57
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-17 -9.04 -10 -13 -12 -6.15 -7.04 -5.78 -14 -0.66
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
15.45 22.83 68.68 0.00 0.00 0.00 43.98 35.17 173.54 126.60
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.23 2.84 3.05 2.45 2.82 2.98 3.69 2.86 4.12 2.63
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
12.94 12.08 10.89 10.12 15.58 17.90 19.82 15.18 25.16 18.31
Enterprise Value to Revenue (EV/Rev)
3.28 2.96 3.31 2.77 3.12 3.26 3.80 2.98 4.26 2.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
2.45 3.89 10.37 -13.62 -4.91 -5.82 6.54 6.26 20.58 22.00
Long-Term Debt to Equity
2.45 3.89 10.37 -13.62 -4.91 -5.82 6.54 6.26 20.58 22.00
Financial Leverage
-0.65 -0.57 0.07 1.01 6.35 -34.46 2.53 6.51 -6.87 -6.07
Leverage Ratio
3.22 4.34 5.13 9.52 36.61 -167.57 15.22 32.61 -29.50 -27.80
Compound Leverage Factor
3.64 5.39 6.28 11.43 46.11 -247.42 22.39 48.26 -36.94 -68.77
Debt to Total Capital
71.05% 79.53% 91.20% 107.92% 125.58% 120.76% 86.74% 86.23% 95.37% 95.65%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
71.05% 79.53% 91.20% 107.92% 125.58% 120.76% 86.74% 86.23% 95.37% 95.65%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
28.95% 20.47% 8.80% -7.92% -25.58% -20.76% 13.26% 13.77% 4.63% 4.35%
Debt to EBITDA
-1.07 -1.20 -1.29 -1.92 -2.14 -2.90 -3.16 -3.95 -3.72 -4.48
Net Debt to EBITDA
-0.09 -0.30 -0.72 -1.08 -1.27 -1.38 -0.62 -0.89 -1.11 -1.27
Long-Term Debt to EBITDA
-1.07 -1.20 -1.29 -1.92 -2.14 -2.90 -3.16 -3.95 -3.72 -4.48
Debt to NOPAT
-1.41 -1.57 -1.66 -2.43 -2.65 -3.49 -3.74 -4.46 -4.25 -5.04
Net Debt to NOPAT
-0.12 -0.39 -0.94 -1.36 -1.57 -1.67 -0.73 -1.01 -1.27 -1.43
Long-Term Debt to NOPAT
-1.41 -1.57 -1.66 -2.43 -2.65 -3.49 -3.74 -4.46 -4.25 -5.04
Altman Z-Score
-1.04 -1.32 -1.55 -1.89 -1.75 -1.08 0.19 -0.15 0.40 -0.26
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.26 2.17 2.07 2.33 1.90 2.33 3.21 2.92 2.47 2.40
Quick Ratio
1.69 1.64 1.35 1.71 1.42 1.93 2.80 2.53 2.13 2.14
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-38 -37 -24 -23 -11 -6.42 -0.83 -5.79 -16 -4.86
Operating Cash Flow to CapEx
-1,896.66% -630.77% -4,028.77% -6,162.04% -171.43% 225.21% -1,331.87% -515.95% -405.82% 353.01%
Free Cash Flow to Firm to Interest Expense
-16.36 -14.09 -8.61 -7.17 -2.93 -1.58 -0.18 -1.23 -3.33 -1.06
Operating Cash Flow to Interest Expense
-7.28 -3.33 -7.38 -4.18 -0.24 0.20 -2.26 -1.38 -1.20 1.05
Operating Cash Flow Less CapEx to Interest Expense
-7.66 -3.86 -7.56 -4.25 -0.39 0.11 -2.43 -1.64 -1.50 0.75
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.68 0.68 0.82 0.89 1.02 1.10 1.14 1.18 1.25 1.26
Accounts Receivable Turnover
8.16 8.01 7.77 6.74 7.19 7.63 7.62 6.58 6.61 6.81
Inventory Turnover
4.60 5.71 4.06 3.34 2.84 4.32 3.86 4.32 4.59 7.25
Fixed Asset Turnover
94.98 74.55 80.26 88.56 92.09 85.94 93.83 102.33 111.76 100.31
Accounts Payable Turnover
7.33 7.83 6.18 5.86 5.48 9.77 6.31 7.93 5.83 12.43
Days Sales Outstanding (DSO)
44.71 45.56 46.96 54.14 50.76 47.84 47.93 55.49 55.20 53.60
Days Inventory Outstanding (DIO)
79.38 63.93 89.99 109.22 128.50 84.44 94.56 84.44 79.51 50.33
Days Payable Outstanding (DPO)
49.82 46.60 59.09 62.24 66.64 37.36 57.88 46.02 62.59 29.36
Cash Conversion Cycle (CCC)
74.28 62.90 77.87 101.12 112.63 94.93 84.61 93.91 72.12 74.58
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
35 36 48 46 37 37 42 47 42 40
Invested Capital Turnover
6.22 6.86 3.94 4.21 5.10 5.51 4.90 5.12 6.28 6.92
Increase / (Decrease) in Invested Capital
26 30 16 12 1.68 0.38 -5.41 0.40 5.02 3.24
Enterprise Value (EV)
458 440 518 467 577 659 835 707 1,058 734
Market Capitalization
452 422 477 414 521 602 811 679 1,022 699
Book Value per Share
$0.52 $0.33 $0.12 ($0.12) ($0.34) ($0.36) $0.32 $0.31 $0.09 $0.09
Tangible Book Value per Share
($0.73) ($0.91) ($1.10) ($1.32) ($1.53) ($1.56) ($0.85) ($0.77) ($0.98) ($1.02)
Total Capital
101 90 79 88 76 100 139 140 127 127
Total Debt
72 72 72 95 95 120 121 121 121 122
Total Long-Term Debt
72 72 72 95 95 120 121 121 121 122
Net Debt
6.14 18 41 53 56 58 24 27 36 35
Capital Expenditures (CapEx)
0.90 1.39 0.51 0.22 0.54 0.36 0.80 1.25 1.41 1.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.90 0.37 12 13 4.77 1.29 6.51 10 4.51 1.43
Debt-free Net Working Capital (DFNWC)
65 54 43 55 43 64 103 104 90 88
Net Working Capital (NWC)
65 54 43 55 43 64 103 104 90 88
Net Nonoperating Expense (NNE)
7.75 5.72 6.36 7.56 7.52 5.79 6.86 5.96 8.34 5.17
Net Nonoperating Obligations (NNO)
6.14 18 41 53 56 58 24 27 36 35
Total Depreciation and Amortization (D&A)
1.39 1.51 1.71 1.74 1.74 1.79 1.83 1.86 1.56 1.91
Debt-free, Cash-free Net Working Capital to Revenue
-0.64% 0.25% 7.64% 7.95% 2.58% 0.64% 2.96% 4.36% 1.82% 0.54%
Debt-free Net Working Capital to Revenue
46.32% 36.53% 27.75% 32.69% 23.53% 31.73% 47.09% 43.84% 36.06% 33.19%
Net Working Capital to Revenue
46.32% 36.53% 27.75% 32.69% 23.53% 31.73% 47.09% 43.84% 36.06% 33.19%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.36) ($0.24) ($0.26) ($0.32) ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11)
Adjusted Weighted Average Basic Shares Outstanding
56.18M 56.07M 56.48M 56.92M 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M
Adjusted Diluted Earnings per Share
($0.36) ($0.24) ($0.26) ($0.32) ($0.30) ($0.20) ($0.22) ($0.18) ($0.30) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding
56.18M 56.07M 56.48M 56.92M 57.02M 56.92M 58.80M 62.72M 63.15M 62.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.25M 56.41M 56.92M 56.97M 57.15M 57.94M 62.61M 63.09M 63.32M 63.59M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -7.45 -7.27 -11 -8.15 -6.04 -5.14 -4.27 -11 -1.62
Normalized NOPAT Margin
-34.45% -17.06% -17.44% -21.45% -16.29% -9.91% -8.66% -6.38% -17.73% -2.05%
Pre Tax Income Margin
-59.78% -30.03% -35.40% -36.71% -33.79% -19.22% -22.01% -16.90% -31.16% -8.04%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-7.67 -4.01 -4.33 -4.75 -3.54 -1.95 -1.89 -1.63 -3.19 -0.56
NOPAT to Interest Expense
-5.35 -2.83 -3.02 -3.33 -2.48 -1.48 -1.33 -1.15 -2.27 -0.35
EBIT Less CapEx to Interest Expense
-8.05 -4.54 -4.51 -4.81 -3.69 -2.04 -2.06 -1.89 -3.49 -0.86
NOPAT Less CapEx to Interest Expense
-5.73 -3.36 -3.21 -3.39 -2.63 -1.57 -1.50 -1.42 -2.57 -0.65
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.49%

Frequently Asked Questions About Evolus' Financials

When does Evolus's fiscal year end?

According to the most recent income statement we have on file, Evolus' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Evolus' net income changed over the last 2 years?

Evolus' net income appears to be on a downward trend, with a most recent value of -$50.42 million in 2024, falling from -$74.41 million in 2022. The previous period was -$61.69 million in 2023.

What is Evolus's operating income?
Evolus's total operating income in 2024 was -$34.41 million, based on the following breakdown:
  • Total Gross Profit: $182.30 million
  • Total Operating Expenses: $216.72 million
How has Evolus revenue changed over the last 2 years?

Over the last 2 years, Evolus' total revenue changed from $148.62 million in 2022 to $266.27 million in 2024, a change of 79.2%.

How much debt does Evolus have?

Evolus' total liabilities were at $227.05 million at the end of 2024, a 8.3% increase from 2023, and a 42.4% increase since 2022.

How much cash does Evolus have?

In the past 2 years, Evolus' cash and equivalents has ranged from $53.92 million in 2022 to $86.95 million in 2024, and is currently $86.95 million as of their latest financial filing in 2024.

How has Evolus' book value per share changed over the last 2 years?

Over the last 2 years, Evolus' book value per share changed from 0.33 in 2022 to 0.09 in 2024, a change of -73.5%.



This page (NASDAQ:EOLS) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners